Xvivo Perfusion AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
XVIVO Perfusion AB Appoints KPMG as New Auditing Company
XVIVO Perfusion AB announced that the Annual General Meeting (AGM) resolved to appoint KPMG as a new auditing company. Mr. Jan Malm has been elected the principal auditor.
Latest Key Developments in Medical
- RION CO LTD raises consolidated full-year outlook for FY 2014
- Shanghai Kehua Bio Engineering issues FY 2014 H1 net profit outlook
- Biomerieux to propose share repurchase program
- Antares Pharma Inc announces publication of a head-to-head, randomized, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis
- Share this
- Digg this